Faruqi & Faruqi Investigates Varonis Securities Litigation
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 28 2026
0mins
Should l Buy VRNS?
Source: Newsfilter
- Legal Investigation: Faruq & Faruq LLP is investigating potential claims against Varonis Systems, Inc. due to a significant miss in annual recurring revenue (ARR) reported on October 28, 2025, which has led to investor losses.
- Stock Price Plunge: Following the earnings announcement on October 28, 2025, Varonis' stock price plummeted from $63.00 to $32.34 per share, representing a dramatic decline of approximately 48.67% in just one day, indicating severe market concerns about the company's growth potential.
- Management Misrepresentation: The lawsuit alleges that Varonis and its executives made overly optimistic statements to investors while failing to disclose critical negative information, resulting in shareholders purchasing securities at artificially inflated prices, thereby harming their interests.
- Investor Rights Protection: Faruq & Faruq LLP reminds investors that March 9, 2026, is the deadline to apply to become the lead plaintiff in the federal securities class action, encouraging affected investors to contact them directly to discuss legal options.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy VRNS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on VRNS
Wall Street analysts forecast VRNS stock price to rise
18 Analyst Rating
14 Buy
4 Hold
0 Sell
Strong Buy
Current: 23.550
Low
37.00
Averages
52.18
High
80.00
Current: 23.550
Low
37.00
Averages
52.18
High
80.00
About VRNS
Varonis Systems, Inc. is a data security company. The Company’s cloud-native data security platform discovers and classifies critical data, removes exposures, and detects advanced threats with artificial intelligence (AI)-powered automation. Varonis software enables enterprises of all sizes and industries to protect data stored in the cloud and on-premises, including sensitive files, emails and databases; confidential personal data belonging to customers, patients and employees; financial records; source code, strategic and product plans; and other intellectual property. Its SaaS product portfolio includes two product lines: its flagship Varonis Data Security Platform, which protects Microsoft 365, Windows file shares, Active Directory, Edge devices (VPN, DNS, proxy), UNIX/Linux and hybrid NAS storage, and DatAdvantage Cloud, which protects IaaS environments and SaaS applications, such as Salesforce, AWS, Azure, Google Cloud, Google Workspace, Databricks, ServiceNow, and others.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Class Action Initiation: Robbins Geller Rudman & Dowd LLP announces that investors who purchased Varonis Systems, Inc. (NASDAQ:VRNS) common stock between February 4, 2025, and October 28, 2025, can seek lead plaintiff status by March 9, 2026, highlighting investor concerns over potential legal risks associated with the company.
- Allegations of Misconduct: The lawsuit alleges that Varonis and certain executives violated the Securities Exchange Act of 1934 by creating a false impression of reliable revenue projections, misleading investors about the company's financial health, which could have long-term repercussions on the company's reputation and stock price.
- Performance Decline Impact: On October 28, 2025, Varonis reported third-quarter results that significantly missed expectations and lowered its full-year guidance, with CEO Yakov Faitelson attributing the shortfall to decreased renewals in both federal and non-federal sectors, resulting in a nearly 49% drop in stock price, reflecting a severe loss of market confidence in the company's growth prospects.
- Legal Process Overview: Under the Private Securities Litigation Reform Act of 1995, any investor who acquired Varonis stock during the class period can apply to be the lead plaintiff, representing all other members in the lawsuit, emphasizing the importance of investor rights and potential economic benefits in legal actions.
See More
- Lawsuit Notification: Hagens Berman is notifying investors in Varonis Systems, Inc. (NASDAQ: VRNS) about the upcoming March 9, 2026, lead plaintiff deadline in a pending securities class action lawsuit against the company and its executives.
- Revenue Decline: The lawsuit alleges that Varonis executives concealed significant renewal softness in its Federal vertical and legacy on-premises business while publicly promoting a transition to its Software-as-a-Service (SaaS) platform, resulting in a 63.9% year-over-year decline in term license revenue disclosed on October 28, 2025.
- Stock Price Crash: This revelation triggered a 48% single-day stock crash, with VRNS shares plummeting from $63.00 to $32.34, erasing approximately $3.8 billion in market value, severely impacting investor confidence and the company's market performance.
- Transition Challenges: The lawsuit highlights that despite Varonis's claims of being on track for a SaaS transition, the company struggled to convince existing customers to migrate, leading to performance misses and reflecting its vulnerability in a competitive market.
See More
- Legal Investigation: Faruqi & Faruqi LLP is investigating potential claims against Varonis Systems, Inc., particularly for investors who purchased or acquired securities between February 4, 2025, and October 28, 2025, indicating concerns over the company's future legal risks.
- Investor Rights Reminder: The firm reminds investors that March 9, 2026, is the deadline to seek the role of lead plaintiff in a federal securities class action, emphasizing the importance of timely action to protect their rights to claims.
- Contact Information Provided: Investors wishing to discuss their legal rights can directly contact Faruqi & Faruqi partner Josh Wilson, with two phone numbers provided to ensure easy access to legal consultation for affected investors.
- Market Reaction Anticipation: The ongoing legal investigation may impact market confidence in Varonis, prompting investors to closely monitor developments to assess potential risks and returns on their investments.
See More
- Class Action Initiation: Bragar Eagel & Squire has filed a class action lawsuit against Varonis in the Southern District of New York on behalf of investors who purchased shares between February 4, 2025, and October 28, 2025, indicating significant legal risks that could exacerbate shareholder losses.
- Poor Financial Performance: Varonis reported third-quarter 2025 results that missed consensus estimates, with a 63.9% year-over-year decline in revenue, and reduced its full-year ARR guidance, highlighting major challenges in sustaining growth and potentially undermining investor confidence.
- Stock Price Plunge: Following the earnings report, Varonis's stock price plummeted by 48.7% to close at $32.34 per share, directly resulting in investor losses and reflecting a pessimistic outlook on the company's future prospects.
- Legal Consultation Opportunity: Investors who suffered losses during the class period are encouraged to contact the law firm to understand their legal rights, indicating that the company's legal liabilities may impact its future capital operations and market performance.
See More
- Class Action Initiated: Bragar Eagel & Squire has filed a class action lawsuit against Varonis in the Southern District of New York on behalf of investors who purchased shares between February 4, 2025, and October 28, 2025, with a deadline of March 9, 2026, for lead plaintiff applications.
- Allegations of Misrepresentation: The complaint alleges that Varonis failed to disclose significant adverse facts about its business and operations during the class period, particularly regarding challenges to its Annual Recurring Revenue (ARR) growth, misleading investors about the company's prospects.
- Declining Financial Performance: Varonis reported third-quarter 2025 results that missed consensus estimates, including a 63.9% year-over-year decline in term license subscription revenues, and subsequently lowered its full-year ARR guidance, indicating weakness in its on-premises subscription business.
- Stock Price Plummet: Following the earnings report, Varonis's stock price fell by $30.66, or 48.7%, closing at $32.34 per share, significantly harming investors and reflecting a pessimistic market sentiment regarding the company's future.
See More
- Class Action Notice: Rosen Law Firm reminds investors who purchased Varonis Systems common stock between February 4, 2025, and October 28, 2025, that they must apply to be lead plaintiff by March 9, 2026, to participate in the class action and potentially receive compensation.
- Lawsuit Background: The lawsuit alleges that Varonis failed to maintain annual recurring revenue (ARR) projections and could not effectively persuade existing customers to transition to the software-as-a-service (SaaS) model, resulting in significantly reduced ARR growth potential and losses for investors.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest securities class action settlement against a Chinese company, being ranked No. 1 by ISS Securities Class Action Services in 2017, demonstrating its expertise and success in this field.
- Investor Guidance: Investors are advised to carefully select law firms with proven success in leadership roles, avoiding those that merely act as intermediaries, to ensure they receive the best legal support and potential compensation in the class action.
See More





